Altimmune to Participate in Upcoming Investor Conferences
Altimmune, Inc. (ALT)
NASDAQ:AMEX Investor Relations:
altimmune.com/investors
Company Research
Source: GlobeNewswire
GAITHERSBURG, Md., March 02, 2026 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing pemvidutide to address serious liver diseases, today announced that management will participate and be available for one-on-one meetings at the following investor conferences: Leerink Global Healthcare Conference Monday, March 9, 2026 – One-on-one meetingsWednesday, March 11, 2026 – Fireside chat at 9:20 a.m. ET Citizens Life Sciences Conference Tuesday, March 10, 2026 – One-on-one meetings Fireside chat at 2:15 p.m. ET Jefferies Biotech on the Beach SummitWednesday, March 11, 2026 – One-on-one meetings only Barclays 28th Annual Global Healthcare ConferenceThursday, March 12, 2026 – One-on-one meetings Fireside chat at 10:30 a.m. ET Webcasts of the fireside chats at the Leerink, Citizens and Barclays conferences will be available via the Events section of the Altimmune website. Registered investors may request meetings on the dates not
Show less
Read more
Impact Snapshot
Event Time:
ALT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ALT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ALT alerts
High impacting Altimmune, Inc. news events
Weekly update
A roundup of the hottest topics
ALT
News
- Altimmune (ALT) had its "market perform" rating reaffirmed by William Blair.MarketBeat
- Altimmune Announces Fourth Quarter and Full-year 2025 Financial Results and Business Updates [Yahoo! Finance]Yahoo! Finance
- Altimmune Announces Fourth Quarter and Full-year 2025 Financial Results and Business UpdatesGlobeNewswire
- Altimmune to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 5, 2026GlobeNewswire
- Altimmune, Inc. (ALT) Gains Analyst Support as Pemvidutide Advances [Yahoo! Finance]Yahoo! Finance
ALT
Earnings
- 3/5/26 - Miss
ALT
Sec Filings
- 3/5/26 - Form 8-K
- 2/27/26 - Form 4
- 2/27/26 - Form 4
- ALT's page on the SEC website